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Abstract
Apoptosis plays an important role in the pathogenesis of reovirus encephalitis. Reovirus outer-capsid protein m1, which
functions to penetrate host cell membranes during viral entry, is the primary regulator of apoptosis following reovirus
infection. Ectopic expression of full-length and truncated forms of m1 indicates that the m1 Q domain is sufficient to elicit a
cell death response. To evaluate the contribution of the m1 Q domain to the induction of apoptosis following reovirus
infection, Q mutant viruses were generated by reverse genetics and analyzed for the capacity to penetrate cell membranes
and elicit apoptosis. We found that mutations in Q diminish reovirus membrane penetration efficiency by preventing
conformational changes that lead to generation of key reovirus entry intermediates. Independent of effects on membrane
penetration, amino acid substitutions in Q affect the apoptotic potential of reovirus, suggesting that Q initiates apoptosis
subsequent to cytosolic delivery. In comparison to wild-type virus, apoptosis-defective Q mutant viruses display diminished
neurovirulence following intracranial inoculation of newborn mice. These results indicate that the Q domain of m1 plays an
important regulatory role in reovirus-induced apoptosis and disease.
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Introduction
Neurological disease is one of the most serious manifestations of
viral infection. A diverse group of neurotropic viruses including
alphaviruses, bunyaviruses, flaviviruses, herpesviruses, and rhab-
doviruses are capable of causing encephalitis. Central nervous
system (CNS) disease following infection by many of these viruses
is associated with neuronal apoptosis [1–5]. Identification of viral
components that engage the cellular machinery to evoke apoptosis
is prerequisite to the development of novel therapeutic targets
against encephalitic viruses. However, limited information exists
about this critical pathogen-host interface.
Mammalian reoviruses are highly tractable models for analysis
of virus-host interactions. Studies using these viruses have provided
significant insights into mechanisms by which viruses initiate
proapoptotic signaling responses that contribute to the pathogen-
esis of viral encephalitis. Following infection of newborn mice,
reoviruses disseminate systemically, producing injury to a variety
of organs, including the CNS, heart, and liver [6]. Infection of
mice with type 3 reovirus results in fatal encephalitis [7–9], which
is associated with extensive apoptosis at sites of viral replication
[10–12]. Modulation of apoptosis in infected animals using
pharmacological inhibitors or through genetic means attenuates
CNS disease, highlighting an important contributory role of
apoptosis to the pathogenesis of encephalitis [11–14].
In cultured cells, reovirus-induced apoptosis does not require de
novo synthesis of viral RNA and protein [15,16], indicating that
the proapoptotic stimulus is contained within infecting viral
capsids. Consistent with these findings, strain-specific differences
in the capacity of reovirus to induce apoptosis segregate genetically
with the viral S1 and M2 gene segments [17–19], which encode
attachment protein s1 and outer-capsid protein m1, respectively
[20,21]. Studies in which s1 attachment to its cognate receptors,
junctional adhesion molecule-A (JAM-A) and sialic acid, was
uncoupled from viral disassembly by providing an alternative
means of cell entry indicate that signaling pathways triggered by
s1-receptor interactions are dispensable for reovirus-induced
apoptosis [16]. Regardless of the receptors used to mediate
attachment, initiation of prodeath signaling following reovirus
infection requires viral disassembly in cellular endosomes [16].
Concordantly, these studies identified the viral M2 gene segment
as the primary determinant of strain-specific differences in reovirus
apoptosis [16], suggesting an essential function for the m1 protein
in apoptosis induction.
PLoS Pathogens | www.plospathogens.org 1 December 2008 | Volume 4 | Issue 12 | e1000248In addition to its structural and proapoptotic functions, the m1
protein plays an essential role in penetration of host cell membranes
during reovirus cell entry. Following uptake into cellular endosomes,
reovirus undergoes proteolytic disassembly resulting in removal of
outer-capsid protein s3 and cleavage of the m1 protein to form the d
and Q fragments (Figure 1A), which remain associated with the
newly generated infectious subvirion particles (ISVPs) [22–25].
ConformationalchangeswithintheISVP-associated d fragment lead
to formation of ISVP*s and allow the autocatalytic cleavage and
release of a small myristoylated N-terminal fragment of m1, m1N
(Figure 1A) [26–30]. The released m1N fragment is thought to
function alone or act in concert with the lipophilic ISVP*s to form
pores in host cell membranes that release the viral core into the
cytoplasm to initiate infection [31,32].
Introduction of single amino acid substitutions into the d region of
m1 decreases the capacity of the resultant mutant viruses to effect
membrane penetration, mobilize proapoptotic transcription factors,
NF-kB and IRF-3, and evoke apoptosis [12]. These findings suggest
that the membrane-penetration and apoptosis-induction functions of
m1 are linked and that the d region of m1 is an essential modulator of
both processes. However, the precise mechanism by which m1-
mediated membrane penetration activates prodeath signaling is not
clear. It is possible that membrane penetration regulated by d or the
physiologicconsequences of membrane rupture initiate proapoptotic
signals. Alternatively, membrane penetration might allow delivery of
the m1 cleavage fragments into the cytoplasm where prodeath
signalingiselicited.Insupportofthelatterpossibility,plasmid-driven
expression of the m1 C-terminal cleavage fragment, Q,i nt h e
cytoplasm is sufficient to induce apoptosis [33]. Therefore, we
hypothesize that membrane penetration by reovirus results in the
delivery of Q into the cytosol where it activates a cellular trigger to
induce apoptosis.
In this study, we evaluated the role of the m1 Q domain in the
reovirus replication cycle by characterizing viruses with amino acid
substitutions within Q. We found that the m1 Q domain regulates
both membrane penetration and apoptosis induction following
reovirus infection. Analogous to mutations in d,w h i c hi m p a i r
membrane penetration by diminishing the efficiency of conforma-
tional changes in m1 that accompany the ISVP-to-ISVP* transition
[12,28,34], mutations in Q also affect membrane penetration by
affecting ISVP* formation. Additionally, our studies indicate that
while mutations in Q modulate prodeath signaling following reovirus
infection, the membrane-penetration and apoptosis-inducing func-
tions of Q can be genetically uncoupled, indicating that initiation of
apoptosis occurs subsequent to membrane penetration. Collectively,
these findings highlight an important role for the m1 Q domain in
both membrane penetration and apoptosis induction following
reovirus infection and enhance a mechanistic understanding of how
these two processes are regulated.
Results
Apoptosis-inducing capacity of ectopically expressed m1
is regulated by amino acid residues 594 and 595
Studies using ectopically expressed m1 indicate that residues
582–611 within the m1 C-terminal cleavage fragment, Q, are
sufficient to induce apoptosis [33]. To better inform selection of
functionally important residues for the generation of mutant
viruses, we constructed plasmids that express mutant m1 proteins
with amino acid substitutions within the minimal functional
domain of Q (residues 582–611) and assessed the capacity of these
constructs to stimulate the activity of effector caspases following
transfection of host cells. For these initial studies, we mutagenized
residues within this region predicted to either influence its helical
nature or modulate its interaction with membranes. This genetic
screen revealed that mutations of Q residues Lys594 and Ile595
substantially diminished apoptosis induction (Figure 1A and data
not shown). To understand the role of these residues in evoking
apoptosis, we assessed the apoptosis-inducing capacity of plasmids
harboring a variety of substitutions at Lys594 and Ile595
(Figure 1B). In comparison to an empty vector control,
transfection of 293T cells with a plasmid expressing wild-type m1
resulted in ,4-fold increase in caspase-3/7 activity. While
substitution of the basic amino acid, lysine at position 594 in m1
with an alanine or arginine did not affect apoptosis efficiency of
the mutant m1 protein, introduction of either aspartic acid or
glutamic acid at that position diminished apoptotic potential.
Similarly, while substitution of the hydrophobic amino acid
isoleucine at position 595 with either alanine or valine did not
affect its capacity to stimulate effector caspase activity, substitution
with either lysine or aspartic acid significantly decreased the
capacity of mutant m1 to stimulate a cell-death response. Steady-
state levels of wild-type and mutant m1 proteins were equivalent
(Figure 1C), suggesting that differences in the capacity of m1
mutants to mediate activation of effector caspases are not related
to differences in the expression or stability of the m1 proteins.
Thus, Lys594 and Ile595 influence the induction of apoptosis
following m1 expression in cells.
Since ectopically expressed m1i sn o tc l e a v e dt og e n e r a t eQ (data
not shown), it is possible that substitutions at Lys594 and Ile595 affect
the capacity of m1 to induce apoptosis through indirect effects on
protein conformation. To evaluate this possibility, we assessed the
apoptotic potential of plasmids expressing wild-type, K594D, or
I595K GFP-tagged Q (Figure 1D). Consistent with our previous
findings [33], expression of wild-type GFP-Q resulted in ,5-fold
increase in effector caspase activity. We found that while a K594D
substitution in GFP-Q did not affect its capacity to stimulate effector
caspase activity, an I595K substitution significantly diminished the
capacity of GFP-Q to induce apoptosis (Figure 1D). Since these effects
do not parallel differences in the steady-state levels of GFP-tagged Q
Author Summary
Many viruses produce central nervous system disease by
infecting and systematically killing host neurons via a
process known as programmed cell death, or apoptosis.
However, for most viruses, it is not understood how viral
invasion is detected by host cells nor how this recognition
triggers a signaling cascade that leads to apoptotic cell
death. We used mammalian reovirus to understand the
intricacies of this virus–host interaction. We found that the
Q domain of reovirus membrane-penetration protein m1
mediates two functions during the reovirus replication
cycle. First, Q affects the efficiency with which reovirus
breaches the host cell membrane barrier. Second, Q
controls the strength of the prodeath signal via its
subcellular localization or its interaction with a cellular
sensor that connects reovirus to the cell death machinery.
Importantly, these effects are independent, as judged by
analysis of mutants displaying discordant alterations in
membrane penetration and apoptosis. Remarkably, we
found that the capacity of reovirus to induce apoptosis
affects its capacity to cause disease. These findings provide
insight into mechanisms by which viruses activate
signaling networks that contribute to cell death and
suggest that the host–pathogen death-signaling interface
is a viable target for therapy against viruses that afflict the
central nervous system.
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PLoS Pathogens | www.plospathogens.org 2 December 2008 | Volume 4 | Issue 12 | e1000248Figure 1. Charge substitutions of m1 Q residues Lys594 and Ile595 diminish apoptosis-inducing capacity of ectopically expressed m1
and Q. (A) Crystal structure of a m1 monomer (PBD:1JMU) [36]. The m1N, d, and Q domains are indicated in red, yellow, and blue, respectively. The
location of a minimal functional region of Q (spanning amino acids 582–611) sufficient for apoptosis induction following expression in cells [33] is
indicated in dark blue. A black box indicates the position of Lys594 and Ile595. (B) 293T cells were transfected with a plasmid expressing either wild-
type or the indicated point-mutant m1 protein. Caspase-3/7 activity in cell lysates was quantified 24 h post-transfection. Results are expressed as the
mean ratio of caspase-3/7 activity from transfected cell lysates to that from empty vector-transfected cells for triplicate samples. Error bars indicate
SD. *, P,0.05 as determined by Student’s t-test in comparison to cells infected with wild-type m1. (C) 293T cells treated with Z-VAD-FMK were
transfected with a plasmid expressing either wild-type or the indicated point-mutant m1 protein. Cell lysates were prepared at 24 h post-transfection,
resolved by SDS-PAGE, and immunoblotted using a MAb specific for m1 (upper panel). As a control for protein concentration, the blots also were
probed with an antibody specific for the PSTAIR peptide of Cdk1 (lower panel). (D) 293T cells were transfected with a plasmid expressing either wild-
type, K594D, or I595K GFP-tagged Q protein. Caspase-3/7 activity in cell lysates was quantified 24 h post-transfection. Results are expressed as the
mean ratio of caspase-3/7 activity from transfected cell lysates to that from empty vector-transfected cells for triplicate samples. Error bars indicate
SD. *, P,0.05 as determined by Student’s t-test in comparison to cells infected with wild-type m1. (E) 293T cells treated with Z-VAD-FMK were
transfected with a plasmid expressing either wild-type, K594D, or I595K GFP-tagged Q protein. Cell lysates were prepared at 24 h post-transfection,
resolved by SDS-PAGE, and immunoblotted using a MAb specific for GFP (upper panel). As a control for protein concentration, the blots also were
probed with an antibody specific for the Cdk1 PSTAIR peptide (lower panel).
doi:10.1371/journal.ppat.1000248.g001
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m1 constructs, indicate that substitutions at Lys594 and Ile595
regulate m1-mediated apoptosis induction via distinct mechanisms.
Whereas K594D likely regulates the apoptosis induction function of
m1b ya f f e c t i n gm1 conformation, I595K appears to influence the
apoptotic potential of mutant m1 proteins as a direct consequence of
alterations in physicochemical properties of Q.
Reovirus Q mutants are viable and display no growth
defects
To evaluate the function of residues 594 and 595 in apoptosis
induction in the context of virus infection, we used reverse genetics
[35] to rescue wild-type recombinant strain type 3 Dearing
(rsT3D) and Q mutant viruses, K594D or I595K, which we
hypothesized to be altered in prodeath signaling (Figure 1). Viruses
with these substitutions in Q were rescued with equivalent
efficiency (data not shown). To determine whether substitutions
in Q affect reovirus infectivity, we quantified the number of L929
cells expressing nascent viral protein following infection with
rsT3D and the mutant viruses (Figure 2A). We found that
infection with either rsT3D or the Q mutants resulted in an
approximately equal number of infected cells. These data suggest
that mutations in Q do not affect the efficiency with which reovirus
establishes infection of host cells. To evaluate whether these
mutations affect the capacity of reovirus to efficiently replicate in
host cells, we infected L929 cells with either rsT3D or the Q
mutant viruses at a multiplicity of infection (MOI) of 2 plaque
forming units (PFU)/cell and quantified viral titer at 0, 12, 24, and
48 h following infection (Figure 2B). At 24–48 h post-infection,
each of the viruses produced ,1000- to 10 000-fold increases in
infectious progeny. In concordance with these findings, no
differences were detected in the replication kinetics of rsT3D,
K594D, and I595K when infection was initiated at an MOI of
0.01 PFU/cell (data not shown). These data indicate that
mutations at Q residues 594 or 595 do not compromise viral
replication kinetics or yield in cell culture.
Mutations in Q affect reovirus membrane-penetration
efficiency
The m1 Q domain incorporates an amphipathic helix that is
hypothesized to function during membrane penetration [24,36]. To
determine whether mutations in Q alter reovirus membrane-
penetration efficiency, we tested the capacity of ISVPs generated
from each mutant virus to lyse erythrocytes (Figure 3A). The
property of reovirus to perturb erythrocyte membrane integrity and
cause hemolysis correlates with endosomal membrane penetration
[12,29,31]. Incubation of bovine erythrocytes with either rsT3D or
I595K resulted in efficient erythrocyte lysis, whereas the K594D
mutant failed to elicit significant levels of hemolysis. To determine
whether the K594D mutant also is altered in penetration of
membranes of reovirus-permissive cells, we tested the capacity of
wild-type and Q mutant viruses to mediate the release of
51Cr from
preloadedL929cells(Figure3B).IncubationofL929cellswitheither
rsT3D or I595K resulted in significantly greater
51Cr release than
did K594D. These data suggest an important role for Q residue
Lys594 in membrane penetration.
As a surrogate measure of the capacity of reovirus to deliver its
core into the cytoplasm, we tested the capacity of rsT3D and the Q
mutants to allow a-sarcin coentry as a consequence of reovirus-
mediated membrane breach (Figure 3C). Inhibition of cellular
protein synthesis following coentry of a-sarcin is determinative of
efficient membrane penetration by reovirus [12,29,37]. Quantifi-
cation of protein-synthesis inhibition 1 h following infection
revealed that rsT3D and I595K efficiently inhibited protein
synthesis in the presence of a-sarcin, whereas K594D did not.
Consistent with results from hemolysis and chromium-release
assays, these findings indicate that Q residue Lys594 regulates viral
membrane-penetration efficiency.
Mutations in Q affect ISVP* formation
Formation of size-selective pores in host cell membranes is
thought to be an essential event during membrane penetration by
reovirus [31]. Conformational changes in m1 that accompany the
conversion of ISVPs to ISVP*s are prerequisite for formation of
pores [28,29,31]. To determine whether mutations in Q diminish
membrane-penetration efficiency by preventing these conformation-
al changes, we evaluated the capacity of K594D and I595K to form
ISVP*s in vitro. As a control, we used a membrane penetration-
defective d mutant virus, A319E [12,34,38], which is inefficient in
ISVP* formation [29]. ISVPs of wild-type and each mutant virus
were incubated with Cs ions, which favor ISVP* formation [28] and
probed for the susceptibility of the m1 d fragment to trypsin digestion
byimmunoblotting(Figure3D).Increased susceptibilityofthe ISVP-
associated d fragment to trypsin in the presence of Cs correlates with
ISVP* formation [29]. Trypsin treatment of Cs-treated ISVPs of
either rsT3D or I595K resulted in rapid degradation of the m1 d
fragment. In contrast, the d fragments of Cs-treated ISVPs of both
K594D and A319E remained resistant to trypsin cleavage for an
extended interval, with the A319E d fragment displaying greater
Figure 2. Infectivity and growth of m1 Q mutants. (A) L929 cells
were adsorbed with rsT3D or the indicated Q mutant at an MOI of 10
4
particles/cell. After incubation at 37uC for 18 h, cells were fixed using
methanol and visualized by immunostaining. Reovirus-infected cells
were quantified by counting fluorescent cells. Results are expressed as
mean fluorescent focus units (FFU) per field for triplicate samples. Error
bars indicate SD. (B) L929 cells were adsorbed with rsT3D or the
indicated Q mutant at an MOI of 2 PFU/cell. Titers of virus in cell lysates
at the indicated intervals post-infection were determined by plaque
assay. Results are expressed as viral yield for triplicate samples. Error
bars indicate SD.
doi:10.1371/journal.ppat.1000248.g002
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indicate that ISVP-to-ISVP* conversion is affected by the K594D
mutation but not the I595K mutation.
As an additional measure of the diminished capacity of m1t o
undergo conformational changes consistent with ISVP* formation,
we evaluated residual infectivity of reovirus ISVPs following
Figure 3. K594D exhibits altered capacity for membrane penetration. (A) A 3% v/v solution of bovine erythrocytes was incubated with
5.4610
10 ISVPs of rsT3D or the indicated Q mutant at 37uC for 1 h. Hemolysis was quantified by determining absorbance of the supernatant at
415 nm. Hemolysis following treatment of an equal number of cells with virion-storage buffer or virion-storage buffer containing 1% TX-100 was
considered to be 0 or 100%, respectively. Results are expressed as mean percent hemolysis for triplicate samples. Error bars indicate SD. *, P,0.05 as
determined by Student’s t-test in comparison to rsT3D. (B) L929 cells preincubated with
51Cr-labeled sodium chromate were adsorbed with 10
5 ISVPs/
cell of rsT3D or the indicated Q mutant at 4uC for 1 h and incubated at 37uC for 4 h following addition of complete medium. The amount of
51Cr
released into the medium was determined by liquid scintillation.
51Cr release following treatment of an equal number of cells with virion-storage
buffer or by addition of 4% TX-100 to the medium was considered to be 0 or 100%, respectively. Results are expressed as mean percent lysis for
triplicate samples. Error bars indicate SD. *, P,0.05 as determined by Student’s t-test in comparison to rsT3D. (C) HeLa cells starved of cysteine and
methionine were adsorbed with 10
6 ISVPs/cell of rsT3D or the indicated Q mutant at 4uC for 1 h. Infection was initiated in medium containing
35S-
labeled cysteine and methionine in the presence or absence of a-sarcin. Cells were lysed following incubation at 37uC for 1 h. Proteins were
precipitated with TCA, and acid-precipitable radioactivity was quantified by scintillation counting. Results are expressed as mean
35S incorporated for
triplicate samples. Error bars indicate SD. *, P,0.05 as determined by Student’s t-test in comparison to
35S incorporated in the absence of a-sarcin. (D)
CsCl-treated ISVPs of rsT3D or the indicated m1 mutant were incubated with trypsin at 4uC for the intervals shown. Samples were resolved by SDS-
PAGE and immunoblotted using a MAb specific for m1. The position of the d band is shown. (E) ISVPs of rsT3D or the indicated m1 mutant were
incubated at the temperatures shown for 15 min. Residual infectivity was assessed by plaque assay. Results are expressed as mean residual titer for
triplicate samples. Error bars indicate SD.
doi:10.1371/journal.ppat.1000248.g003
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efficiency of ISVP-to-ISVP* transition correlates with enhanced
thermal stability of reovirus ISVPs [39]. Incubation of either
rsT3D or I595K ISVPs for 15 min at temperatures$42uC
resulted in at least a 10 000-fold reduction in infectivity. In
contrast, infectivity of A319E ISVPs remained unchanged at
temperatures up to 47uC and was diminished only ,100-fold
following incubation at 52uC. Like A319E, incubation of K594D
ISVPs at temperatures up to 42uC had no effect on infectivity.
However, ,100- and 10 000-fold decreases in K594D infectivity
were observed following incubation at 47uC and 52uC, respec-
tively. These data demonstrate that K594D displays thermal
stability intermediate to that of rsT3D and A319E and suggest that
Lys594 modulates the conformational flexibility of m1.
Reovirus Q mutants are apoptosis defective
Residues Lys594 and Ile595 in m1 Q modulate apoptosis
induction following ectopic expression in cells (Figure 1). To
determine whether these residues also are important for apoptosis
induction during reovirus infection, we compared the apoptotic
potential of wild-type and Q mutant viruses by acridine orange
staining (Figure 4A). Following infection of HeLa cells with rsT3D,
,30–35% of cells showed altered nuclear morphology character-
istic of apoptosis. However, infection with the K594D or I595K
elicited apoptosis in only ,12% of cells. As a complementary
approach, we used propidium iodide staining and flow cytometry
to compare the capacity of these viruses to promote DNA
fragmentation in infected cells (Figure 4B). Infection of HeLa cells
with rsT3D resulted in ,50% cells displaying hypodiploid (sub-
G1) DNA staining, characteristic of apoptotic cells. In contrast,
infection with either K594D or I595K resulted in a percentage of
cells in sub-G1 that was comparable to mock infection. These
results suggest that the apoptotic potential of reovirus is regulated
by Q residues Lys594 and Ile595.
Activation of transcription factor NF-kB is required for induction
of apoptosis in cultured cells following infection with reovirus
[40,41]. To test whether the limited apoptotic potential of the Q
mutants is linked to a defect in the activation of NF-kB signaling, the
capacity of wild-type and mutant viruses to stimulate NF-kB activity
was quantified using a reporter assay (Figure 4C). For these
experiments, 293T cells were transfected with a reporter plasmid
that expresses firefly luciferase under the control of an NF-kB-
regulated promoter. A plasmid that constitutively expresses Renilla
luciferase was used to normalize for transfection efficiency. In
comparison to mock-infected 293T cells, infection with rsT3D
resulted in ,4-fold increase in NF-kB-dependent gene expression.
In contrast, no more than 2.5-fold stimulation of NF-kB reporter
gene activity was observed following infection with the Q mutants
K594D or I595K. These data suggest that the residues in Q required
for apoptosis induction also regulate NF-kB activation following
reovirus infection. Furthermore, since the I595K mutant effectively
penetrates membranes but fails to efficiently activate proapoptotic
signaling,thesefindingsindicatethatthe membrane-penetration and
apoptosis-induction functions of the m1 Q domain can be genetically
uncoupled. Collectively, these results suggest that initiation of
reovirus-induced proapoptotic signaling is mediated by Q and occurs
following penetration of endosomal membranes.
Q mutant m1 associates inefficiently with intracellular
membranes
The capacity of ectopically expressed m1 to induce apoptosis
correlates with its distribution to intracellular membranous
structures such as mitochondria, endoplasmic reticulum, and lipid
droplets [33]. Moreover, a short loop and amphipathic helix
within w (residues 582 to 611) is necessary and sufficient for
association of m1 with intracellular membranous structures and
induction of apoptosis [33] and contains residues Lys594 and
Ile595. To determine whether the decrease in apoptotic potential
Figure 4. K594D and I595K are apoptosis-defective. (A) HeLa cells
were infected with rsT3D or the indicated Q mutant at an MOI of 100
PFU/cell. Following 48 h incubation, the percentage of apoptotic cells
was determined after staining with acridine orange. Results are
expressed as the mean percentage of apoptotic cells for triplicate
samples. Error bars indicate SD. *, P,0.05 as determined by Student’s t-
test in comparison to rsT3D. (B) HeLa cells were infected with rsT3D or
the indicated Q mutant at an MOI of 100 PFU/cell. Following 48 h
incubation, the percentage of cells with less than G1 DNA content (sub-
G1) was quantified by staining with propidium iodide. Results are
expressed as the mean percentage of sub-G1 cells for triplicate samples.
Error bars indicate SD. *, P,0.05 as determined by Student’s t-test in
comparisonto rsT3D. (C) 293Tcells were co-transfected with pNF-kB-Luc
and pRenilla-Luc 24 h prior to adsorption with rsT3D or the indicated Q
mutant at an MOI of 100 PFU/cell. Luciferase activity in cell lysates was
determined at 24 h post-infection. Results are presented as the ratio of
normalized luciferase activity from infected cell lysates to that from
mock-infected lysates for triplicate samples. Error bars indicate SD. *,
P,0.05 as determined by Student’s t-test in comparison to rsT3D.
doi:10.1371/journal.ppat.1000248.g004
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capacity of mutant m1 to associate with intracellular membranes,
we compared the distribution of wild-type and mutant m1 proteins
in infected CV-1 cells by immunofluorescence microscopy
(Figure 5A). Consistent with previous findings [33], infection with
rsT3D and each of the Q mutant viruses resulted in three
discernable m1 distribution patterns: (i) diffuse cytoplasmic
distribution, (ii) incorporation within viral inclusions, or (iii)
localization to intracellular membranes structures. Although m1
was found in all three locations following infection with rsT3D,
K594D, and I595K, a lower fraction of cells displayed diffuse m1
localization following infection with either of the Q mutants
(,15%) in comparison to rsT3D (,30%) (Figure 5B). Similarly,
m1 localized to intracellular membrane fractions in a significantly
lower percentage of cells following infection with either K594D
(,35%) or I595K (,20%) in comparison to rsT3D (,50%).
Concordant with the decrease in m1 distribution throughout the
cytoplasm and to intracellular membranes, a considerably higher
fraction of cells showed m1 within viral inclusions following
infection with the Q mutants (,80%) in comparison to wild-type
virus (,50%). Thus, mutations in Q that modulate apoptosis
induction affect m1 distribution in cells.
Mutations in Q diminish reovirus virulence in the CNS
Intracranial inoculation of 2 d old mice with type 3 reovirus
strains such as T3D at doses as low as 10 PFU produces lethal
encephalitis [7–9]. To determine whether in vitro differences in
Figure 5. Apoptosis-modulating Q mutations alter m1 distribution in cells. (A) CV-1 cells were infected with 10 PFU/cell of rsT3D or the
indicated Q mutant, fixed 48 h post-infection, permeabilized, and immunostained with anti-m1 MAb 4A3 (green) and anti-mNS serum (red), followed
by goat anti-mouse IgG conjugated to Alexa Fluor 488 (green) and goat anti-rabbit IgG conjugated to Alexa Fluor 594 (red). Scale bars, 10 mm. A
representative image of the predominant m1 distribution pattern following infection with each virus strain is shown. (B) The patterns of m1
distribution in individual infected cells were scored for each time point as diffuse, associated with viral inclusions, or associated with intracellular
membranes (marked by distinct ring-like distribution of m1). Results are expressed as the mean percentage of cells showing the indicated m1
distribution for triplicate samples. Error bars indicate SD. *, P,0.05 as determined by Student’s t-test in comparison to rsT3D.
doi:10.1371/journal.ppat.1000248.g005
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disease, we inoculated newborn mice intracranially with 50 PFU
of either rsT3D or the apoptosis-defective Q mutants, K594D or
I595K, and monitored mice for survival and signs of neurological
disease for an interval of 21 d (Figure 6A). We noted a significant
difference in the survival of mice infected with rsT3D and either
K594D or I595K. The median survival for rsT3D-infected mice
was 11 d. In contrast, median survival for K594- or I595K-
infected mice was 13 d. Moreover, a substantially greater
proportion of mice survived infection with the Q mutant viruses
(,30%) in comparison to those infected with rsT3D (,15%).
These data indicate that Q residues Lys594 and Ile595 influence
reovirus neurovirulence.
To determine whether the delay in disease onset following
infection with the Q mutants results from delayed viral replication
kinetics, mice infected with rsT3D, K594D, and I595K were
euthanized at 2, 4, 6, 8, and 10 d after infection, and viral titers in
resected brains were quantified by plaque assay (Figure 6B).
Following infection with rsT3D, viral titers increased rapidly in the
mouse brain to reach a peak titer of ,10
9 PFU/ml by 8 d post-
inoculation. Apoptosis-defective mutants K594D and I595K also
displayed similar replication kinetics and attained titers equivalent
to rsT3D by 8 d post-inoculation. These data indicate that K594D
and I595K replicate as efficiently as wild-type virus in the murine
CNS and that alterations in viral replication kinetics in vivo are
not likely to contribute to the decreased capacity of Q mutant
viruses to produce fatal encephalitis.
To evaluate the extent of injury in the CNS of mice infected
with rsT3D, K594D, and I595K, we examined hematoxylin and
eosin (H&E)-stained, coronal brain sections from mice euthanized
at 10 d following intracranial viral inoculation (Figure 7A, top
panel and 7B). Mice infected for 10 d were selected for these
histopathological analyses since virus strains used in this study
displayed maximal titers at that time point. Sections from rsT3D-
infected mice showed the presence of reactive blood vessels and
infiltration by inflammatory cells and extensive neuronal death in
the cerebral cortex, hippocampus, thalamus, and hypothalamus.
Consistent with previous reports [10–12], these characteristic
pathological features indicate that intracranial inoculation of
rsT3D results in overt meningoencephalitis. The hippocampal
region of mice infected with rsT3D showed extensive damage to
layers CA3 and CA4, with the pyramidal cells displaying classical
apoptotic nuclear morphology (Figure 7B). In addition, microcys-
tic changes and neuronal apoptosis also were evident in the
dentate gyrus of rsT3D-infected mice. In contrast, the hippocam-
pal region of the brains of mice inoculated with either K594D or
I595K displayed minimal damage, with evidence of only focal
apoptosis or necrosis in both the CA3 layer and the dentate gyrus
(Figure 7B). These findings suggest that K594D and I595K
produce less pathological injury than wild-type virus in the murine
CNS.
Figure 6. Apoptosis-defective Q mutants display attenuated
virulence. ND4 Swiss Webster mice were inoculated intracranially with
50 PFU of rsT3D or the indicated Q mutant. (A) Mice (18–20) were
monitored for survival over 21 days. *, P,0.05 as determined by logrank
test in comparison to rsT3D. (B) Brains from infected mice were resected
at the times shown and homogenized by freeze-thaw and sonication.
Viral titers in brain homogenates were determined by plaque assay.
Results are expressed as the mean viral titer (for 6–12 animals). Error
bars indicate SD.
doi:10.1371/journal.ppat.1000248.g006
Figure 7. Q mutant viruses produce less histopathologic injury
than wild-type virus. ND4 Swiss Webster mice were inoculated
intracranially with 50 PFU of rsT3D or the indicated Q mutant. (A) Brains
from infected mice were resected at 10 d post-inoculation, fixed, and
embedded in paraffin. Brain sections were stained with H&E, polyclonal
reovirus-specific antiserum, or activated caspase-3-specific antiserum.
Consecutive sections from the hippocampal region of representative
brains of rsT3D-, K594D-, or I595K-infected mice are shown. Scale bars,
500 mm. (B) Higher magnification images of H&E-stained sections of the
dentate gyrus and CA4 region of the hippocampus of mice infected
with each virus strain are shown. Scale bars, 100 mm.
doi:10.1371/journal.ppat.1000248.g007
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injury result from alterations in viral tropism due to mutations at
Lys594 and Ile595, infected mouse brain sections consecutive to
those used in the H&E analyses were stained with reovirus-specific
antiserum (Figure 7A, middle panel). Immunoreactive neurons were
detected in the cerebral cortex, hippocampus, thalamus, and
hypothalamus of mice infected with rsT3D, K594D, and I595K.
Despite discernable differences in virus-induced cell death and
inflammation in mouse brains infected with rsT3D and Q mutant
viruses, localization of viral antigen was similar in mice infected with
bothtypesofviruses.Althoughdifferencesareevidentintheintensity
ofreovirus-specificstaining inthe hippocampusofmiceinfected with
rsT3D, K594D, or I595K, the specific brain regions infected by
these viruses were similar (Figure 6B). These data indicate that
mutations in Q that affect either its membrane-penetration or
apoptosis-induction function do not alter reovirus tropism.
To qualitatively assess whether rsT3D and the Q mutants vary
in the capacity to elicit apoptosis in vivo, sections from infected
mouse brains were stained with an antiserum specific for the
activated form of caspase-3 as a biochemical marker for apoptosis
(Figure 7A, lower panel). In mice infected with rsT3D, regions of
the hippocampus immunoreactive for viral antigen also were
positive for activated caspase-3. In contrast, a substantially lower
fraction of cells stained for activated caspase-3 following infection
with either K594D or I595K. These data suggest that the
diminished virulence of K594D and I595K is a consequence of
decreased apoptotic potential.
Q mutants are apoptosis-defective in vivo
To quantitatively test whether the Q mutant viruses differ from
wild-type virus in apoptosis-inducing capacity, we examined brain
homogenates at 6, 8, and 10 d post-inoculation for the activated
formofcaspase-3byimmunoblotting(Figure8A).Activatedcaspase-
3 levels in the brain homogenates of five randomly selected mice
following infection with each virus strain were normalized to the
levelsofactin (Figure8B).Ateach intervaltested,brainhomogenates
from mice infected with rsT3D displayed a substantially higher level
of activated caspase-3 in comparison to those infected with either
K594D or I595K. Although the mean viral titers in the brains of
mice infected with rsT3D, K594D, and I595K are equivalent
(Figure 6B), it is possible that differences in the concentration of
activated caspase-3 in an individual mouse brain (shown in
Figure 7B) are a consequence of differences in viral replication. To
control for such differences, the in vivo apoptotic potential of each
virus was expressed as a ratio of the concentration of activated
caspase-3 per PFU of virus (Figure 8C) for each infected mouse
brain. In comparison to rsT3D, we found significantly lower levels of
activated caspase-3/PFU following infection with K594D (,70-fold)
andI595K(,10-fold)at8 dpostinfection.Althoughapoptosislevels
increaseat10 d postinfectionfollowinginfectionwitheachvirus,the
activated caspase-3/PFU ratio remained lower following infection
with K594D (,8-fold) and I595K (,3-fold) in comparison to
rsT3D. These dataindicate thatthe Q mutant virusesare defective in
apoptosis induction in vivo and provide further evidence that the
attenuated virulence of K594D and I595K is attributable to a
reduced capacity to evoke apoptotic cell death.
Discussion
Apoptosis induction following reovirus infection is regulated by
the m1 viral outer-capsid protein. In this study, we evaluated the
role of the m1 Q domain in apoptosis induction following reovirus
infection by characterizing viruses with single amino acid
substitutions within Q. We found that the reovirus Q domain
regulates two important processes in the reovirus infectious cycle.
First, residues in Q influence reovirus membrane-penetration
efficiency during cell entry by preventing conformational changes
in m1 that accompany the ISVP-to-ISVP* transition. Second,
mutations in Q affect the capacity of reovirus to activate NF-kB
and induce apoptosis. Importantly, these effects are independent:
I595K, an apoptosis-defective Q mutant, is fully capable of
penetrating membranes. These findings highlight a critical
Figure 8. Q mutant viruses are apoptosis-defective in vivo. ND4
Swiss Webster mice were inoculated intracranially with 50 PFU of rsT3D
or the indicated Q mutant. Brains from infected mice were resected at
the times shown and homogenized by freeze-thaw and sonication. (A)
Brain homogenates were resolved by SDS-PAGE and immunoblotted
using an antiserum specific for activated caspase-3 (C-3) (upper panel).
As a control for protein concentration, the blots were stripped and
reprobed with an antibody specific for actin (lower panel). (B) Brain
homogenates from five animals infected with each virus strain for the
times shown were resolved by SDS-PAGE and immunoblotted using
antisera specific for either activated caspase-3 or actin. Pixel intensities
of activated caspase-3 and actin bands were quantified by densitom-
etry. Results are expressed as the mean ratio of activated caspase-3
band intensity to that of actin. Error bars indicate SEM. *, P,0.05 as
determined by Student’s t test in comparison to rsT3D at each time
point. (C) For each brain homogenate, the cleaved caspase-3/actin ratio
obtained by immunoblot analysis was divided by the virus titer. Results
are expressed as the mean activated caspase-3 concentration/PFU. Error
bars indicate SEM. *, P,0.05 as determined by Student’s t test in
comparison to rsT3D at each time point.
doi:10.1371/journal.ppat.1000248.g008
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apoptosis induction following reovirus infection and suggest that
initiation of apoptosis following reovirus infection occurs subse-
quent to penetration of endosomal membranes.
Structure-function relationships in m1 that govern its mem-
brane-penetration activity are poorly defined. Following genera-
tion of ISVPs, conformational changes in m1 triggered by the
endocytic milieu lead to generation of ISVP*s [28]. These
conformational changes facilitate membrane penetration by
promoting efficient cleavage and release of the myristoylated N-
terminal m1 fragment, m1N [30,42], which interacts with
membranes to allow osmotic rupture [31,32]. Analogous to
m1N, the Q fragment also is released from the particle during
ISVP-to-ISVP* transition triggered by exposure to CsCl and
associates with target membranes [32]. Although released Q is not
sufficient for membrane penetration, m1N-mediated membrane
penetration is more efficient in the presence of released Q [32].
Based on these observations, Q has been hypothesized to function
as a m1N chaperone and facilitate membrane penetration by
enhancing m1N solubility or preventing nonproductive interactions
between m1N molecules [32]. Results presented here suggest that
Q residue Lys594 regulates conformational changes that accom-
pany ISVP-to-ISVP* formation. Since release of the myristoylated
m1N fragment requires ISVP* formation, the diminished mem-
brane-penetration efficiency of K594D is likely attributable to the
decreased propensity of the mutant m1 protein to undergo the
conformational changes that lead to release of m1N. Although our
data do not exclude a role for Q as a m1N chaperone, results
reported here indicate an additional mechanism by which Q
influences m1N function.
Analysis of the ISVP*-associated m1 protein using antibodies
that recognize conformation-specific epitopes within d and
measurement of d protease sensitivity indicate that ISVP*
formation is accompanied by changes in d conformation [29].
Concordantly, amino acid substitutions in d that enhance thermal
stability of reovirus particles [39] or render them resistant to 33%
ethanol [34,38] prevent conformational changes in d. Data
gathered in this study indicate that mutations within Q also
modulate conformational rearrangements in d during ISVP*
formation. Since both m1N and Q are released from the virus
particle during ISVP* formation [32], it is likely that conforma-
tional rearrangements in m1 during ISVP* formation are not
restricted to the d domain and also involve the m1N and Q
domains. The model of membrane penetration suggested by the
crystal structure of the native m1 trimer also supports the idea that
a coordinated set of conformational rearrangements are required
to allow release of these cleavage fragments [36,43]. Therefore,
amino acid substitutions within Q that negatively affect the
conformational flexibility of Q would likely prevent m1 reorgani-
zation required for ISVP* formation. Biochemical and structural
characterization of additional mutant viruses that may be affected
to varying degrees in the capacity to undergo m1 conformational
changes may identify as yet unknown intermediates during ISVP-
to-ISVP* conversion and offer insight into mechanisms that
promote the elaborate remodeling of the m1 protein that is
required to mediate membrane penetration.
Correlation of reovirus membrane-penetration efficiency with
its apoptotic potential suggests that the apoptotic cascade is
initiated as a consequence of membrane penetration [12].
However, prior to this study, it was not apparent whether the
linkage between membrane penetration and apoptosis induction
was direct or indirect. Findings presented here demonstrate that a
membrane penetration-proficient m1 mutant is apoptosis-defective,
indicating that the Q domain activates prodeath signaling
subsequent to membrane penetration. It is probable that like the
d domain [29], the released Q domain also gains access to the
cytoplasm after penetration of endosomal membranes. We
hypothesize that following delivery into the cytoplasm, the Q
domain engages a cellular sensor to activate NF-kB and possibly
other proapoptotic signaling pathways that function cooperatively
to evoke cell death [44–46]. Although the fate of released Q
following successful membrane penetration during reovirus entry
is unknown, Q may localize to intracellular membranous structures
such as mitochondria, ER, and lipid droplets similar to that
observed following ectopic expression of epitope-tagged Q in
transfected cells [33]. Since localization of m1 to these sites is
required for its prodeath function and is attributable to residues
582–611 within the Q fragment [33], distribution of de novo
synthesized m1 was used as a surrogate for Q distribution following
cell entry of reovirus. Consistent with previous observations, the
K594D and I595K m1 proteins displayed subcellular distribution
that differed from wild-type m1. In comparison with the wild-type
m1 protein, the mutant m1 proteins were found to localize less
efficiently to intracellular membranes. In addition, Q mutant m1
proteins also displayed diminished localization to the cytoplasm.
These findings are consistent with the idea that Q initiates
prodeath signaling following localization to intracellular mem-
branes or cytoplasm.
We envision three mutually non-exclusive mechanisms by
which Q may modulate prodeath signaling. First, Q may activate
apoptotic signaling via engagement of a cell-death regulator
resident either in the mitochondria or ER. For example, Q could
interact with and modify the function of either the proapoptotic or
anti-apoptotic members of the Bcl-2 family that are known to
localize to both of these organelles [47]. These interactions could
directly activate classical apoptotic pathways that contribute to
reovirus-induced cell death. Second, Q could stimulate prodeath
signaling by affecting mitochondrial membrane potential [48,49]
or calcium ion levels in the ER lumen [50]. In support of this
possibility, Q preferentially localizes to these organelles [33] and
contains an amphipathic helix [24,36] that may be capable of pore
formation following interaction with membranes. Third, Q might
activate NF-kB through engagement of a cytoplasmic or organelle-
associated cellular factor that stimulates IkB kinase (IKK) activity.
Although it is known that reovirus-induced NF-kB activation
requires the function of IkB kinase (IKK) complex components
IKKa and IKKc/NEMO [41], the signal transducer that couples
reovirus to these IKK subunits is not defined. Q also may activate
IKKs via direct interaction with IKK components analogous to
the HTLV Tax protein, which stimulates IKK activity via
interaction with IKKc/NEMO [51,52]. Our future studies will
elucidate how Q evokes proapoptotic signaling.
In addition to enhancing an understanding of molecular
mechanisms underlying reovirus-induced proapoptotic signaling,
our findings also indicate that the prodeath function of Q
modulates reovirus neurovirulence. These findings are consistent
with previous studies that link the apoptosis-inducing capacity of
reovirus to its virulence potential [10–14] and suggest that
apoptosis efficiency controls virulence through adverse effects on
viral replication or by interfering with host physiology. Since
diminishment in apoptotic efficiency of Q mutant reoviruses is not
associated with a reduction in viral replication efficiency at the
target site of disease, our data suggest that apoptosis directly affects
reovirus pathogenesis. Because infection by type 3 reoviruses such
as those used in this study leads to encephalitis marked by
destruction of a non-renewable, post-mitotic neuronal cell
population, it is possible that the morbidity and mortality caused
by reovirus infection in mice is a consequence of apoptotic cell
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also indicate that in comparison to the Q mutant viruses, infection
by wild-type rsT3D results in greater influx of inflammatory cells,
suggesting that inflammation-induced injury to neurons contrib-
utes to reovirus pathogenesis. This conclusion is consistent with
previously suggested roles for inflammatory mediators such as IL-
1b in reovirus CNS disease [53]. Although it is not known how
inflammation is initiated in response to viral infection, it is possible
that reovirus-induced activation of NF-kB, which is a known
proinflammatory transcription factor [54], also contributes to viral
disease independent of effects on virus-induced apoptosis.
Analogous to reovirus, apoptosis induction by dengue virus [2],
rabies virus [55], Sindbis virus [56], and West Nile virus [57]
correlate with neurovirulence potential. Since viral encephalitis
appears to be a common consequence of neuronal apoptosis, these
findings collectively identify virus-induced proapoptotic signaling
as a viable target for therapy against viruses that infect the CNS.
Consistent with this relationship, agents that protect neurons from
apoptotic cell death ameliorate viral encephalitis [13,14,57].
Results presented here enhance an understanding of events at
the virus-host interface that lead to activation of prodeath signaling
and provide a platform for illumination of therapeutic targets that
may be broadly applicable to encephalitic viruses.
Materials and Methods
Cells
HeLa cells and 293T cells were maintained in DMEM
(Invitrogen) supplemented to contain 10% fetal bovine serum
(FBS), 2 mM L-glutamine, 100 U/ml of penicillin, 100 mg/ml
streptomycin, and 25 ng/ml of amphotericin B (Sigma-Aldrich).
L929 cells were maintained in Joklik’s MEM (Sigma-Aldrich)
supplemented to contain 10% FBS, 2 mM L-glutamine, 100 U/
ml of penicillin, 100 mg/ml streptomycin, and 25 ng/ml of
amphotericin B. CV-1 cells were maintained in Ham’s F-12
medium (CellGro) supplemented to contain 10% FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin, 1 mM sodium pyruvate, and
nonessential amino acids (CellGro).
Viruses
Recombinant reoviruses were generated by plasmid-based
reverse genetics [35]. Monolayers of L929 cells at approximately
90% confluence (3610
6 cells) in 60 mm dishes (Costar) were
infected with rDIs-T7pol [58] at an MOI of , 0.5 TCID50.A t1h
post-infection, cells were cotransfected with ten plasmid constructs
representing the cloned T3D genome using 3 ml of TransIT-LT1
transfection reagent (Mirus) per mg of plasmid DNA. Following
5 d of incubation, recombinant virus was isolated from transfected
cells by plaque purification using monolayers of L929 cells [59].
For generation of m1 mutant viruses, pT7-M2T3D [35] was
altered by Quickchange (Stratagene) site-directed mutagenesis. To
confirm sequences of mutant viruses, viral RNA was extracted
from purified virions and subjected to Onestep RT-PCR (Qiagen)
using L1 or M2-specific primers. (Primer sequences are available
from the corresponding authors upon request.) The purified PCR
products were subjected to sequence analysis for the presence of
the introduced mutation in the M2 gene segment and the
noncoding signature mutation in the L1 gene segment [35].
Purified reovirus virions were prepared using second- or third-
passage L929-cell lysate stocks of twice plaque-purified reovirus as
described [60]. Viral particles were Freon-extracted from infected
cell lysates, layered onto CsCl gradients, and centrifuged at
62,0006g for 18 h. Bands corresponding to virions (1.36 g/cm
3)
[61] were collected and dialyzed in virion-storage buffer (150 mM
NaCl, 15 mM MgCl2, 10 mM Tris-HCl [pH 7.4]). The concen-
tration of reovirus virions in purified preparations was determined
from an equivalence of one OD unit at 260 nm equals 2.1610
12
virions [61]. Viral titer was determined by plaque assay using
L929 cells [59]. ISVPs were generated by incubation of 2610
12
virions with 200 mg/ml of N-p-tosyl-L-lysine chloromethyl ketone-
treated chymotrypsin in a total volume of 0.1 ml at 37uC for either
20 min (for Cr- release assays) [34] or 1 h [62]. Proteolysis was
terminated by addition of 2 mM phenylmethylsulphonyl fluoride
and incubation of reactions on ice. Generation of ISVPs was
confirmed by SDS-polyacrylamide gel electrophoresis and Coo-
massie Brilliant Blue staining.
Antibodies and plasmids
Antisera raised against T1L and T3D [63], mNS [64], and m1-
specific monoclonal antibody (MAb) 4A3 [65] have been
described. Rabbit antiserum specific for activated caspase-3 was
purchased from Cell Signaling. GFP-specific MAb was purchased
from Clontech. Goat antiserum specific for actin was purchased
from Santa Cruz Biotechnology. Mouse ascites specific for the
PSTAIR peptide of Cdk1 was purchased from Sigma-Aldrich.
Alexa Fluor-conjugated anti-mouse IgG, anti-rabbit IgG, and anti-
goat IgG secondary antibodies were purchased from Invitrogen.
The m1 ORF was amplified by PCR from viral RNA and cloned
into pCR-script (Stratagene). The XhoI-NotI fragment released
from pCR-script was ligated into complementary restriction sites
in pCI-neo (Promega) to generate pCI-M2. Plasmids encoding
mutant m1 proteins were generated using pCI-M2 and Quick-
change site-directed mutagenesis. The T3D Q ORF was amplified
by PCR from pT7-M2T3D and cloned into pCR-script. The
XhoI-SmaI fragment released from pCR-script was ligated into
complementary restriction sites in pEGFP-C1 (Clontech) to
generate GFP-tagged Q.
Plasmids pRenilla-Luc and pNF-kB-Luc [51] were obtained
from Dr. Dean Ballard.
Assessment of m1 and GFP-Q expression by
immunoblotting
293T cells (2610
5) in 24-well plates (Costar) were treated with
50 mM Z-VAD-FMK (Biomol) and transfected with 0.8 mg/well
of plasmids expressing wild-type or mutant T3D m1 or GFP-Q
proteins using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. At 24 h following transfection, cells
were washed in phosphate-buffered saline (PBS) and lysed with 16
RIPA (50 mM Tris [pH 7.5], 50 mM NaCl, 1% TX-100, 1%
DOC, 0.1% SDS, and 1 mM EDTA) containing a protease
inhibitor cocktail (Roche). Following centrifugation at 15 0006g to
remove debris, the cell lysates were resolved by electrophoresis in
4–20% polyacrylamide gels and transferred to nitrocellulose
membranes. Membranes were blocked for at least 1 h in blocking
buffer (PBS containing 5% milk) and incubated with 1 mg/ml of
anti-m1 MAb 4A3 or an anti-GFP MAb and anti-PSTAIR ascites
diluted 1:10 000 in blocking buffer at room temperature for 1 h.
Membranes were washed three times for 10 min each with
washing buffer (PBS containing 0.1% Tween-20) and incubated
with Alexa Fluor 680-conjugated goat anti-mouse Ig diluted
1:10 000 in blocking buffer. Membranes were washed three times
and scanned using a Odyssey Infrared Imager (LiCor).
Assessment of caspase-3/7 activity
293T cells (2610
5) in 24-well plates were transfected with
0.8 mg/well of plasmids expressing wild-type or mutant m1 GFP-Q
proteins using Lipofectamine 2000 according to the manufactur-
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caspase-3/7 activity in thawed lysates containing 5610
3 cell
equivalents was quantified using the Caspase-Glo-3/7 assay
system (Promega) according to the manufacturer’s instructions.
Assessment of viral infectivity by indirect
immunofluorescence
L929 cells (2610
5) in 24-well plates were adsorbed with reovirus
at room temperature for 1 h. Following removal of the inoculum,
cells were washed with PBS and incubated in complete medium at
37uC for 18 h to permit completion of a single cycle of viral
replication. Monolayers were fixed with methanol, washed twice
with PBS, blocked with 2.5% immunoglobulin-free bovine serum
albumin (Sigma-Aldrich) in PBS, and incubated successively for
1 h with polyclonal rabbit anti-reovirus serum at a 1:1000 dilution
and a 1:1000 dilution of Alexa Fluor 546-labeled anti-rabbit IgG.
Monolayers were washed with PBS, and infected cells were
visualized by indirect immunofluorescence using a Zeiss Axiovert
200 fluorescence microscope. Infected cells were identified by the
presence of intense cytoplasmic fluorescence that was excluded
from the nucleus. No background staining of uninfected control
monolayers was observed. Reovirus antigen-positive cells were
quantified by counting fluorescent cells in at least two random
fields of view in triplicate wells at a magnification of 206 or by
counting the entire well for duplicate wells.
Assessment of virus replication by plaque assay
L929 cells (2610
5) in 24-well plates were adsorbed in triplicate
with reovirus at room temperature for 1 h in serum-free medium,
washed once with PBS, and incubated in serum-containing
medium for various intervals. Cells were frozen and thawed twice
prior to determination of viral titer by plaque assay using L929
cells [59]. Viral yields were calculated according to the following
formula: log10yieldx=log10(PFU/ml)x2log10(PFU/ml)0, where x
is the time post-infection.
Hemolysis assay
Citrated calf red blood cells (RBCs) (Colorado Serum
Company) were washed extensively with chilled PBS supplement-
ed to contain 2 mM MgCl2 (PBS-Mg) and resuspended at a
concentration of 30% v/v in PBS-Mg. Hemolysis efficiency was
analyzed by mixing a 3 ml aliquot of resuspended RBCs with
virion-storage buffer, 1% TX-100 in virion-storage buffer, or
ISVPs in a total volume of 30 ml, followed by incubation at 37uC
for 1 h. Samples were placed on ice for 30 min to prevent further
hemolysis and centrifuged at 5006g at 4uC for 3 min. The extent
of hemoglobin release was quantified by measuring the A415 of a
1:5 dilution of the supernatant in a microplate reader (Molecular
Devices). Percentage hemolysis was calculated using the following
formula: % hemolysis=1006(Asample2Abuffer)/(ATX-1002Abuffer).
Chromium-release assay
A 0.5 ml suspension of L929 cells at a concentration of 4610
6
cells/ml was incubated in serum-free medium supplemented to
contain 100 mCi
51Cr-labeled sodium chromate (Perkin Elmer) at
37uC for 2 h. Cells were pelleted by centrifugation at 10006g for
5 min, washed twice with chilled PBS, and divided into aliquots of
6610
4 cells. Cells were adsorbed with ISVPs of each virus strain at
4uC for 1 h. Infection was initiated following removal of unbound
ISVPs by washing with chilled PBS and addition of 0.25 ml pre-
warmed complete medium. Spontaneous and total
51Cr release
from cells was determined following mock infection or treatment
with 4% Triton X-100, respectively. Cells were transferred to 96-
well plates (Costar) and incubated at 37uC for 4 h. The plates were
centrifuged at 10006g at room temperature for 5 min to pellet
unattached cells. The amount of
51Cr released into 25 mlo f
medium was quantified by liquid scintillation. Percent lysis was
calculated using the following formula: % lysis=1006(cpmsample2
cpmmock)/(cpmTX-1002cpmmock).
a-sarcin coentry assay
HeLa cells (2610
4) in 96-well plates were preincubated in serum-
free, cysteine- and methionine-free DMEM (Invitrogen) at 37uCf o r
3 h. Cells were pre-chilled at 4uC for 1 h and adsorbed with ISVPs
at 4uC for 1 h. Infection was initiated following removal of unbound
ISVPs by washing with chilled PBS and addition of pre-warmed,
cysteine- and methionine-free DMEM supplemented to contain 5%
FBS, 22 mCi/ml of
35S-labeled methionine-cysteine (Perkin Elmer),
and either 0 or 50 mg/ml a-sarcin (Calbiochem). After incubation at
37uC for 1 h, cells were lysed using 16RIPA buffer, and proteins
were precipitated following addition of chilled trichloroacetic acid
(TCA) to a final concentration of 30% and incubation overnight at
4uC. Precipitates were washed successively with 10% TCA and 95%
ethanol, air dried, and solubilized in 50 mM unbuffered Tris
containing 0.05% SDS. TCA-precipitable radioactive counts were
quantified by liquid scintillation to assess incorporation of
35S-
labeled amino acids into nascent proteins.
Analysis of ISVP* generation
ISVPs (2610
11) were incubated with 300 mM CsCl at 32uC for
20 min, transferred to ice for 20 min, and incubated with 100 mg/
ml trypsin at 4uC for various intervals. Trypsin digestion was
terminated by addition of SDS-PAGE loading buffer and removal
of the samples to dry ice. Samples were resolved by electrophoresis
in 4–20% polyacrylamide gels and immunoblotted using a m1-
specific MAb.
Measurement of thermal stability
ISVPs in virion storage buffer were incubated at various
temperatures for 15 min and transferred to ice for 1 h. Residual
infectivity in triplicate samples was assessed by plaque assay [59].
Quantification of apoptosis by acridine orange staining
HeLa cells (5610
4) in 24-well plates were adsorbed with
reovirus at room temperature for 1 h. The percentage of apoptotic
cells after 48 h incubation was determined using acridine orange
staining as described [17]. For each experiment, .200 cells were
counted, and the percentage of cells exhibiting condensed
chromatin was determined by epi-illumination fluorescence
microscopy using a fluorescein filter set (Zeiss).
Quantification of apoptosis by propidium iodide staining
HeLa cells (1610
6) in 6-well plates were adsorbed with reovirus
at room temperature for 1 h, followed by incubation for 48 h.
Cells were harvested and fixed in chilled 70% ethanol by overnight
incubation at 4uC. The percentage of cells showing hypodiploid
nuclei was assessed by flow cytometry following incubation of fixed
cells with DNA staining solution (1 mg/ml sodium citrate, 0.3%
TX-100, 100 mg/ml propidium iodide, and 50 mg/ml RNase A)
for 30 min [66].
Luciferase assays
293T cells in 24-well plates were transfected with 0.72 mg/well
of an NF-kB reporter plasmid, which expresses firefly luciferase
under NF-kB control (pNF-kB-Luc), and 0.08 mg/well of control
plasmid pRenilla-Luc, which expresses Renilla luciferase consti-
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transfected cells were adsorbed with reovirus in serum-free
medium at room temperature for 1 h, followed by incubation at
37uC in serum-containing medium for 24 h. Luciferase activity in
the cultures was quantified using the Dual-Luciferase Assay Kit
(Promega) according to the manufacturer’s instructions.
Analysis of cellular distribution of m1
CV-1 cells grown on cover slips (Fisher) were infected with
reovirus and incubated at 37uC for 48 h. Cells were fixed in 2%
paraformaldehyde in PBS at room temperature for 10 min,
washed three times with PBS, and permeabilized using PBS
containing 1% bovine serum albumin (BSA) and 0.1% Triton X-
100 (PBSA-T) or 0.5% saponin for 5 min. Cells were incubated
with primary or secondary antibodies in PBSA-T or PBS
containing 1% BSA and 0.05% saponin at room temperature
for 25 to 40 min. Coverslips were washed three times in PBS
between primary and secondary antibody incubations. Cell nuclei
were labeled by incubation of coverslips with 300 nM 49,69-
diamidino-2-phenylindole (DAPI) (Invitrogen). Coverslips were
mounted on glass slides with Prolong reagent (Invitrogen).
Fluorescence and phase-contrast images were obtained using a
Nikon TE2000 inverted microscope equipped with a 6061.4 NA
oil objective with 1.56 optical zoom. Images were collected
digitally using a Coolsnap HQ charge-coupled-device camera
(Roper) and Openlab software (Improvision) and prepared for
publication using Photoshop and Illustrator software (Adobe
Systems).
Infection of mice
Two-day-old ND4 Swiss Webster mice (Harlan) were inoculat-
ed intracranially with purified rsT3D, K594D, or I595K in a
volume of 5 ml into the left cerebral hemisphere using a Hamilton
syringe and 30-gauge needle [9]. For analysis of viral virulence,
mice were monitored for survival and symptoms of neurological
disease for 21 d. Mice were euthanized when they were found to
be moribund (defined by rapid or shallow breathing, lethargy, or
paralysis). For analysis of virus growth, mice were euthanized at
various intervals following inoculation, and brains were collected
into 1 ml of PBS and homogenized by freezing, thawing, and
sonication. Viral titers in brain homogenates were determined by
plaque assay [59]. Animal husbandry and experimental proce-
dures were performed in accordance with Public Health Service
policy and approved by the Vanderbilt University School of
Medicine Institutional Animal Care and Use Committee.
Histology of mouse brains
Two-day-old ND4 Swiss Webster mice were inoculated
intracranially with rsT3D, K594D, or I595K. Mice were
euthanized, brains were resected, and brain tissues were fixed
overnight in 10% formalin, followed by 70% ethanol. Fixed organs
were embedded in paraffin, and 6-mm histological sections were
prepared. Consecutively obtained sections were stained with H&E
for evaluation of histopathologic changes or processed for
immunohistochemical detection of reovirus protein or activated
caspase-3 [11].
Assessment of apoptosis in brain homogenates
Two-day-old ND4 Swiss Webster mice were inoculated
intracranially with purified rsT3D, K594D, or I595K. Mice were
euthanized at various intervals following inoculation, and brains
were collected into 1 ml of PBS and homogenized by freezing,
thawing, and sonication. Brain homogenates were diluted 10-fold
in 16 RIPA, and 10–20 mg of protein extract was resolved by
electrophoresis in 4–20% polyacrylamide gels and transferred to
nitrocellulose membranes. Membranes were blocked for at least
1 h in Tris-buffered saline (TBS, 50 mM Tris [pH 7.5], 150 mM
NaCl) containing 5% milk or 2.5% BSA and incubated with
primary antibodies diluted 1:500 (for the activated form of
caspase-3) or 1:2000 (for actin) in blocking buffer (TBS containing
milk or BSA) at room temperature for 1 h. Membranes were
washed three times for 10 min each with washing buffer (TBS
containing 0.1% Tween-20) and incubated with Alexa Fluor 680-
or Alexa Fluor 750-conjugated goat anti-rabbit (for caspase-3) or
donkey anti-goat (for actin) Ig, respectively, diluted 1:10 000 in
blocking buffer. Membranes were washed three times and scanned
using a LiCor Odyssey Infrared Imager. Intensities of pixels within
the caspase-3 and actin bands were quantified using Odyssey
software.
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